vaccine (rsvpref) of stabilized f subunit in prefusion against respiratory syncytial virus

Spain

Drugs containing this active substance

  • AREXVY POWDER AND SUSPENSION FOR INJECTABLE SUSPENSION

    It is a vaccine designed to help protect adults aged 18 years and older against respiratory syncytial virus (RSV), a virus that can cause lung infections and other respiratory complications.

    Form: powder and suspension for injectable suspension

    Active substance Dosage
    vaccine (rsvpref) of stabilized f subunit in prefusion against respiratory syncytial virus 120 µg

    ATC: J07B J07BX J07BX05

    Manufacturer: Glaxosmithkline Biologicals